Thyroid Disease Management and Radiation Exposure
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

This session provides a thorough review of thyroid disease and its relationship to radiation exposure, particularly to releases of Iodine 131 from nuclear facilities.  Experts discuss thyroid disease—including its types, symptoms, diagnoses, and treatments; the background, methods, and results of the Hanford Thyroid Disease Study; an overview of the new ATSDR Case Study in Environmental Medicine on Iodine 131; and questions and answers from the audience.

At the end of this session, the user will be able to:

1. Explain the appropriate test for evaluation of the thyroid nodule and the use and
    limitations of thyroid FNA biopsies
2. Explain the utility of T4 suspension of TSH for nodule therapy
3. Explain the classification, general treatment, and follow-up of thyroid cancer
4. Discuss the health effects associated with exposure to power frequency
    magnetic fields
5. Summarize the results of the Hanford Thyroid Disease Study and articulate
    the challenges faced in conducting the study the interpreting the results
6. Explain the evaluation of patients using the three elements basic to
    thyroid screening

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Introductory Remarks from the Moderator
L.B. Sandy Rock, MD, MPH, Interpretive Consultants, Inc.
View Presentation

Diagnosis and Management of Thyroid Nodules and Thyroid Cancer
Jerome Hershman, MD, VA Greater Los Angeles Healthcare Center, UCLA School of Medicine
View Presentation

The Hanford Thyroid Disease Study

  •  An Overview of the Study and a Summary of the Results
    Paul Garbe, DVM, MPH, Centers for Disease Control and Prevention
    Scott Davis, PhD, Fred Hutchinson Cancer Center, University of Washington

  • Evaluating the Hanford Downwinder
    Gayle Brewer, MD, Director of Nuclear Medicine, Yakima Regional Medical Center

View Presentations

ATSDR Case Studies in Environmental Medicine: Iodine 131
Oscar Tarrago, MD, MPH, CHES, Agency for Toxic Substances and Disease Registry, Division of Health Education and Promotion
View Presentation